These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22842847)

  • 21. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.
    D'Abramo A; Zingaropoli MA; Oliva A; D'Agostino C; Al Moghazi S; De Luca G; Iannetta M; Mastroianni CM; Vullo V
    Mediators Inflamm; 2014; 2014():192594. PubMed ID: 25374442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34+/CD144+ circulating endothelial cells as an indicator of carotid atherosclerosis.
    Sugimoto T; Hosomi N; Nezu T; Takahashi T; Aoki S; Takeda I; Mukai T; Ochi K; Kitamura T; Ohtsuki T; Matsumoto M
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):583-90. PubMed ID: 25542764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between endothelial progenitor cells and arterial stiffness in patients with psoriasis.
    Liu JH; Chen Y; Zhen Z; Yeung CK; Chan J; Chan HH; Tse HF; Yiu KH
    J Dermatol; 2016 Aug; 43(8):888-93. PubMed ID: 26704131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis.
    Chironi G; Walch L; Pernollet MG; Gariepy J; Levenson J; Rendu F; Simon A
    Atherosclerosis; 2007 Mar; 191(1):115-20. PubMed ID: 16620831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy.
    Desvarieux M; Boccara F; Meynard JL; Bastard JP; Mallat Z; Charbit B; Demmer RT; Haddour N; Fellahi S; Tedgui A; Cohen A; Capeau J; Boyd A; Girard PM
    AIDS; 2013 Oct; 27(16):2603-14. PubMed ID: 24100713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function.
    Sun D; Wu Y; Yuan Y; Wang Y; Liu W; Yang J
    Atherosclerosis; 2015 Sep; 242(1):109-16. PubMed ID: 26188532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.
    Bernal Morell E; Serrano Cabeza J; Muñoz Á; Marín I; Masiá M; Gutiérrez F; Cano A
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):648-53. PubMed ID: 27005326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
    Currier JS; Kendall MA; Zackin R; Henry WK; Alston-Smith B; Torriani FJ; Schouten J; Mickelberg K; Li Y; Hodis HN;
    AIDS; 2005 Jun; 19(9):927-33. PubMed ID: 15905673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis.
    Moreno-Perez O; Reyes-Garcia R; Muñoz-Torres M; Merino E; Boix V; Reus S; Giner L; Alfayate R; Garcia-Fontana B; Sanchez-Paya J; Picó A; Portilla J
    Clin Endocrinol (Oxf); 2018 Oct; 89(4):414-423. PubMed ID: 29947044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial stiffness and carotid intima-media thickness in HIV infected patients.
    Papita A; Albu A; Fodor D; Itu C; Cârstina D
    Med Ultrason; 2011 Jun; 13(2):127-34. PubMed ID: 21655539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
    Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
    Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension.
    Lau KK; Chan YH; Yiu KH; Li SW; Tam S; Lau CP; Kwong YL; Tse HF
    J Hum Hypertens; 2007 Jun; 21(6):445-51. PubMed ID: 17361211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort.
    Maggi P; Bellacosa C; Leone A; Volpe A; Ricci ED; Ladisa N; Cicalini S; Grilli E; Viglietti R; Chirianni A; Bellazzi LI; Maserati R; Martinelli C; Corsi P; Celesia BM; Sozio F; Angarano G
    Atherosclerosis; 2017 Aug; 263():398-404. PubMed ID: 28522147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.
    Stein JH; Ribaudo HJ; Hodis HN; Brown TT; Tran TT; Yan M; Brodell EL; Kelesidis T; McComsey GA; Dube MP; Murphy RL; Currier JS
    AIDS; 2015 Sep; 29(14):1775-83. PubMed ID: 26372383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals.
    Piconi S; Parisotto S; Rizzardini G; Passerini S; Meraviglia P; Schiavini M; Niero F; Biasin M; Bonfanti P; Ricci ED; Trabattoni D; Clerici M
    AIDS; 2013 Jan; 27(3):381-9. PubMed ID: 23079800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
    Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
    Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease.
    Lekakis J; Tsiodras S; Ikonomidis I; Palios J; Poulakou G; Rallidis L; Antoniadou A; Panagopoulos P; Papadopoulos A; Giamarellou H; Kremastinos DT
    Clin Sci (Lond); 2008 Sep; 115(6):189-96. PubMed ID: 18251713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.